Deal Announcements

Aveo Pharmaceuticals Floats NASDAQ IPO

Tuesday, March 16, 2010 5:36:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts  --  Cancer therapeutics company Aveo Pharmaceuticals went public last week, raising a gross proceeds of $81 million in its initial public offering (IPO).

Aveo says that it is focused on "the discovery and development of novel cancer therapeutics."

The company boasted a large number of institutional venture capital, private equity and strategic investors.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1